Binder Formulations Utilizing Furanic Components
Battelle Memorial Institute
Contact BMI About This Technology
Publications:
View Patent Application Here (115 KB)
- 5-hydroxymethyl furfural (HMF);
- 2,5-furan dimethylol (FDM);
- 2,5-furan dicarboxylic acid (FDCA);
- 2,5-diformyl furan (DFF);
- FDCA monoalkyl ester (hemiester);
- FDM-ether; and
- HMF-ether;
- that cures in the presence of a catalyst gas
Benefits• Cost advantages include reduced raw material costs and increased productivity based on high available volumes of fructose, which is the starting material for HMF
• Primary performance advantages are increased core strength, further reduction of individual unit costs, and rapid decomposition properties to aid core removal from metal castings
• Quality advantages include reduced resin usage, cleaner running tooling, reduced downtime, and reproducible quality parts
Applications and Industries• Foundry cold-box process - mass production of cores and molds.
• Potential expansion into adhesive applicationsPatents and Patent Applications
ID Number |
Title and Abstract | Primary Lab |
Date |
|---|---|---|---|
Application 20080207795 |
Binder Formulations Utilizing Furanic Components
Broadly, the invention provides for a cold-box aggregate binder typically being a mixture of phenolic or urea resin and a furanic material selected from one or more of the group consisting of 5-hydroxymethyl furfural (HMF); 2,5-furan dimethylol (FDM); 2,5-furan dicarboxylic acid (FDCA); 2,5-diformyl furan (DFF); FDCA monoalkyl ester (hemiester); FDM-ether; and HMF-ether; that cures in the presence of a catalyst gas. |
01/22/2008
Filed |
| Development Stage | Availability | Published | Last Updated |
|---|---|---|---|
| Development | Available | 06/11/2012 | 06/21/2012 |